MCUJF
I just bought some Medicure. I know it's not cheap by this board's normal standards but it's a fast grower. 2015 revenues grew 300% over 2014 and revenues may be about 50% higher in 2016 than 2015. They are a profitable biotech, earning $0.26 over the ttm, giving them a trailing PE of about 25. That's not bad though, considering their profit in 2015 was $.08 so they've grown profits over 200% in the last 12 months. They just closed a deal to buy a majority stake in a drug manufacturer. They had a reasonable amount of debt before the transaction but they pay it down consistently. The new deal was financed in all debt, though, so that's a concern. Some warrants also included in the deal have an exercise price of $6.50 so there should be somewhat of a floor in the stock here. Insiders own about 18% of the company.
